← Leaderboards
Robyn Guymer
Monash University
$812,191
Attributed
$1,624,381
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $350.8K · FY2016–20$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,624,381 · 1
By mechanism
R01$1,624,381 · 1
Top collaborators
- John James Mcneil5 shared
Others in their field
Top investigators on “Dietary Supplements”
- Anastassios G Pittas · Tufts Medical Center$49,695,816
- Ikhlas Ahmad Khan · University Of Mississippi$39,794,183
- Joann Elisabeth Manson · Brigham And Women'S Hospital$26,110,300
- John Anthony Baron · Dartmouth College$23,369,919
- Julie E Buring · Brigham And Women'S Hospital$21,370,238
- Charles Hebert · Southern Research Institute$20,298,000
Research focus
Dietary SupplementsData AnalysesCost EffectivenessDepositionAncillary StudyAdjudicateAffectAspirinAtrophicControlled Clinical TrialsBaseBenefits And RisksAgedCardiovascular SystemClinically SignificantAge GroupClinical TrialsCohortCollectionColorAustraliaAge Related Macular DegenerationComplementDigital
Grant awards (5)
Randomized controlled trial of the effect of low dose aspirin on the course of age-related macular degeneration$246,269
R01 · FY2020 · EY
Randomized controlled trial of the effect of low dose aspirin on the course of age-related macular degeneration$350,790
R01 · FY2019 · EY
Randomized controlled trial of the effect of low dose aspirin on the course of age-related macular degeneration$349,854
R01 · FY2018 · EY
Randomized controlled trial of the effect of low dose aspirin on the course of age-related macular degeneration$348,949
R01 · FY2017 · EY
Randomized controlled trial of the effect of low dose aspirin on the course of age-related macular degeneration$328,519
R01 · FY2016 · EY